Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Ferretti

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cellsStefano Laurora, Stefania Pizzimenti, Federica Briatore, et al.
The Journal of Nutritional Biochemistry|September 8, 2009
4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activityStefania Pizzimenti, Elisa Menegatti, Daniela Berardi, et al.
Journal of Cellular and Molecular Medicine|November 17, 2009
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cellsCristina Toaldo, Stefania Pizzimenti, Angelo Cerbone, et al.
Antioxidants & Redox Signaling|November 4, 2014
Role of 4-hydroxynonenal-protein adducts in human diseasesGiuseppina Barrera, Stefania Pizzimenti, Eric Stefano Ciamporcero, et al.
Antioxidants (Basel, Switzerland)|February 25, 2016
Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation ProductsGiuseppina Barrera, Fabrizio Gentile, Stefania Pizzimenti, et al.
PPAR Research|May 24, 2012
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer CellsAngelo Cerbone, Cristina Toaldo, Stefania Pizzimenti, et al.
Plos One|July 5, 2012
Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cellsAngelo Cerbone, Cristina Toaldo, Rosalba Minelli, et al.
British Journal of Clinical Pharmacology|January 4, 2017
Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantationPier Luigi Calvo, Loredana Serpe, Andrea Brunati, et al.
Free Radical Biology & Medicine|May 18, 2016
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defensesMartina Daga, Chiara Ullio, Monica Argenziano, et al.
International Journal of Cardiology|July 14, 2016
Use of remote monitoring in the management of ICD end-of-life: Data from the DECODE registryAndrea Campana, Fabrizio Giofrè, Giuseppe Stabile, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cellsStefano Laurora, Stefania Pizzimenti, Federica Briatore, et al.
The Journal of Nutritional Biochemistry|September 8, 2009
4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activityStefania Pizzimenti, Elisa Menegatti, Daniela Berardi, et al.
Journal of Cellular and Molecular Medicine|November 17, 2009
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cellsCristina Toaldo, Stefania Pizzimenti, Angelo Cerbone, et al.
Antioxidants & Redox Signaling|November 4, 2014
Role of 4-hydroxynonenal-protein adducts in human diseasesGiuseppina Barrera, Stefania Pizzimenti, Eric Stefano Ciamporcero, et al.
Antioxidants (Basel, Switzerland)|February 25, 2016
Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation ProductsGiuseppina Barrera, Fabrizio Gentile, Stefania Pizzimenti, et al.
PPAR Research|May 24, 2012
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer CellsAngelo Cerbone, Cristina Toaldo, Stefania Pizzimenti, et al.
Plos One|July 5, 2012
Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cellsAngelo Cerbone, Cristina Toaldo, Rosalba Minelli, et al.
British Journal of Clinical Pharmacology|January 4, 2017
Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantationPier Luigi Calvo, Loredana Serpe, Andrea Brunati, et al.
Free Radical Biology & Medicine|May 18, 2016
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defensesMartina Daga, Chiara Ullio, Monica Argenziano, et al.
International Journal of Cardiology|July 14, 2016
Use of remote monitoring in the management of ICD end-of-life: Data from the DECODE registryAndrea Campana, Fabrizio Giofrè, Giuseppe Stabile, et al.
Pageof 5